| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/12/2006 | EP1644513A2 Assay and kits for detecting protein binding |
| 04/12/2006 | EP1644509A1 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 04/12/2006 | EP1644508A1 Gene expression system |
| 04/12/2006 | EP1644505A1 A yeast model for amyloidogenic protein toxicity |
| 04/12/2006 | EP1644502A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 04/12/2006 | EP1644501A1 Ssx-2 peptides presented by hla class ii molucules |
| 04/12/2006 | EP1644496A2 Modified vectors for organelle transfection |
| 04/12/2006 | EP1644489A2 Novel immune booster compound, compositions comprising the same and methods using said booster compound |
| 04/12/2006 | EP1644487A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 04/12/2006 | EP1644483A2 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 04/12/2006 | EP1644480A2 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 04/12/2006 | EP1644477A2 Polynucleotides encoding novel adiponectin receptor variants |
| 04/12/2006 | EP1644414A2 Binding molecules against sars-coronavirus and uses thereof |
| 04/12/2006 | EP1644411A2 Stabilised insulin compositions |
| 04/12/2006 | EP1644409A1 Complement depletion using recombinant human c3-derivatives |
| 04/12/2006 | EP1644408A1 Eimeria tenella antigen for immunotherapy of coccidiosis |
| 04/12/2006 | EP1644407A1 Uses of a novel eimeria gene and corresponding protein |
| 04/12/2006 | EP1644406A2 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 04/12/2006 | EP1644405A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 04/12/2006 | EP1644404A2 Antigenic peptides of sars coronavirus and uses thereof |
| 04/12/2006 | EP1644402A1 Arginine/lysine-enriched peptides |
| 04/12/2006 | EP1644048A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| 04/12/2006 | EP1644037A2 Functional influenza virus-like particles (vlps) |
| 04/12/2006 | EP1644034A1 Packaged virus-like particles |
| 04/12/2006 | EP1644032A1 Inhibitors of cell migration |
| 04/12/2006 | EP1644031A1 Inhibitors of the leukocyte prommp-9/beta(2) integrin complex |
| 04/12/2006 | EP1644028A2 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 04/12/2006 | EP1644018A2 Soluble clca-1 and antagonists to clca-1 |
| 04/12/2006 | EP1644016A2 Inhibition of the activity of myelin associated glycoprotein (mag) for regulating nerve growth and regeneration |
| 04/12/2006 | EP1643959A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 04/12/2006 | EP1643894A2 Methods, kits and antibodies for detecting parathyroid hormone |
| 04/12/2006 | EP1578196A4 Mda-7 and free radicals in the treatment of cancer |
| 04/12/2006 | EP1540008A4 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 04/12/2006 | EP1346230B1 Screening method based on tsap6 binding partners |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1299416B1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 04/12/2006 | EP1250435B1 Human neurexin-like proteins and polynucleotides encoding the same |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1185548B1 Method for drying protein crystals |
| 04/12/2006 | EP1140968B1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 04/12/2006 | EP1115828B1 Laundry detergent and/or fabric care compositions comprising a chemical entity which contains a deposition aid with a high affinity for cellulose, a surfactant and a protease |
| 04/12/2006 | EP1100821B1 Anti-inflammatory compounds derived from lipocortin-1 |
| 04/12/2006 | EP1003868B1 Wheat rht gene for genetic control of plant growth and development |
| 04/12/2006 | EP1000150B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 04/12/2006 | EP0985046B1 Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| 04/12/2006 | EP0972042B1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 04/12/2006 | EP0950062B1 Protein markers for esophageal cancer |
| 04/12/2006 | EP0942739B1 Biomaterial derived from vertebrate liver tissue |
| 04/12/2006 | EP0877547B1 Plant glutamate receptors |
| 04/12/2006 | EP0866878B1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 04/12/2006 | EP0861319B1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 04/12/2006 | EP0843726B1 Opioid antagonists and methods of their use |
| 04/12/2006 | EP0491824B2 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 04/12/2006 | CN1759184A Expression vectors comprising the MCMV IE2 promoter |
| 04/12/2006 | CN1759177A Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 04/12/2006 | CN1759174A Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms, and the use of the same |
| 04/12/2006 | CN1759173A Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof |
| 04/12/2006 | CN1759123A Uses of IL-23 agonists and antagonists; related reagents |
| 04/12/2006 | CN1759122A Methods and compositions involving MDA-7 |
| 04/12/2006 | CN1759121A Purification process for bacterial cytolysin |
| 04/12/2006 | CN1757738A Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
| 04/12/2006 | CN1757730A Wheat antidisense related gene TaEDR1 and its application |
| 04/12/2006 | CN1757727A Gene clone of and expression Japan lamprey oral cavity gland KGD model protein possessing anti thrombotic action |
| 04/12/2006 | CN1757724A Use of multiple recombination sites with unique specificity in recombinational cloning |
| 04/12/2006 | CN1757651A Interleukin-17 acceptor, and its coding gene and application |
| 04/12/2006 | CN1757650A Method for extracting insulin type growth factor-1 from fresh pilose antler |
| 04/12/2006 | CN1757413A Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250729C A method of extracellular production of target proteins employing OmpF in e coli |
| 04/12/2006 | CN1250727C Pesticidal fusions |
| 04/12/2006 | CN1250725C Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/12/2006 | CN1250724C Gene involved in epigenetic gene silencing |
| 04/12/2006 | CN1250723C Genetic control of plant growth and development |
| 04/12/2006 | CN1250722C Method for secretion and prodn. of protein |
| 04/12/2006 | CN1250721C Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 04/12/2006 | CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms |
| 04/12/2006 | CN1250569C Keratin solution solid preparing process |
| 04/12/2006 | CN1250568C Protein participating in activation of nitrile hydratase and gene encoding the same |
| 04/12/2006 | CN1250567C Method of purifying calcium ion-binding protein |
| 04/12/2006 | CN1250566C Chemically modified polypeptides |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/11/2006 | US7026530 Wooden leg gene, promoter and uses thereof |
| 04/11/2006 | US7026525 Comprising a recombinant plasmid having the following order of nucleotide sequences: an artificial consensus splicing acceptor site,a synthetic "stop/start" sequence, a reporter gene; a drug resistance gene; a gene for a detectable phenotype of the fly;and a synthetic splicing donor site; cloning |
| 04/11/2006 | US7026524 Human coagulation factor VII variants |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026466 Serotonin-gated anion channel |
| 04/11/2006 | US7026465 Fusion proteins of Mycobacterium tuberculosis |
| 04/11/2006 | US7026464 Natural promoters for gene expression in C1 metabolizing bacteria |
| 04/11/2006 | US7026463 Lactobacillus enzymes for improving flavor and fermentation characteristics in fermented dairy products such as cheese and yogurt; immunostimulants |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026460 lovE variant regulator molecules |
| 04/11/2006 | US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 04/11/2006 | US7026452 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 04/11/2006 | US7026451 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 04/11/2006 | US7026450 Ma family polypeptides and anti-Ma antibodies |
| 04/11/2006 | US7026449 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/11/2006 | US7026448 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/11/2006 | US7026447 53 human secreted proteins |